Work is in progress in the following areas:

  • Developing immunotherapeutic nanoparticles for eradication of Mycobacterium tuberculosis

  • Designing novel biomimetic nanoparticles for immunotherapy and drug delivery

  • Developing inhalable drug loaded microparticles for treatment of pulmonary tuberculosis

  • Studying the interaction of nanoparticles and the biological environment

  • Synthesizing nanoparticles for drug delivery across complex biological barriers

  • Application of biomaterials and nanoparticles towards tissue engineering